SFI
CABA icon

Susquehanna Fundamental Investments’s Cabaletta Bio CABA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,324
Closed -$150K – 1469
2021
Q3 		$150K Buy
+12,324
New +$114K ﹤0.01% 1581
2021
Q1 		– Sell
-12,020
Closed -$150K – 1532
2020
Q4 		$150K Sell
12,020
-7,964
-40% -$103K ﹤0.01% 1394
2020
Q3 		$217K Buy
+19,984
New +$230K 0.01% 1170

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Susquehanna Fundamental Investments's CABA Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Cabaletta Bio (CABA) in Q4 2021, closing a stake of 12,324 shares — an estimated $150K sold.

Susquehanna Fundamental Investments first reported a position in CABA in Q3 2020 and held it in 3 quarters. The position peaked at $217K in Q3 2020. 66 funds tracked by Wall St. Rank hold CABA as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Cabaletta Bio position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 12,324 Cabaletta Bio shares in Q4 2021, an estimated $150K.
  • Susquehanna Fundamental Investments first reported a position in Cabaletta Bio in Q3 2020 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Cabaletta Bio position peaked at $217K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.